Evaluación del uso de Omeprazol en pacientes de la Farmacia Principal Municipal de Placetas, Villa Clara
Fecha
2021
Autores
Bravo López, Elizabeth
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad Central ¨Marta Abreu¨ de Las Villas. Facultad de Química y Farmacia. Departamento de Farmacia
Resumen
Los fármacos gastroprotectores más utilizados son los inhibidores de la bomba de protones (IBP) y dentro de estos, Omeprazol. Desde que los IBP se introdujeron con este fin su consumo aumentó hasta el 450 %. En ocasiones la prescripción del Omeprazol a nivel comunitario con uso gastroprotector es inadecuada, lo que conlleva a un uso irracional del fármaco. El objetivo de este trabajo fue evaluar la prescripción de Omeprazol en el tratamiento de enfermedades gastrointestinales en pacientes de la Farmacia Principal Municipal de turno permanente U-655 del municipio Placetas, Villa Clara en el período de enero-julio del 2021. Se realizó un estudio descriptivo, retrospectivo, de corte transversal. La muestra quedó conformada por 250 pacientes. Predominó el consumo de Omeprazol en féminas. El grupo de más de 60 años fue superior con 76.4 %. El 37.2 % cuenta con formación del Nivel Superior. Mayormente las prescripciones estuvieron indicadas por Gastroenterólogos por no más de 90 días. Principalmente los errores en la prescripción se observaron en Medicina General Integral con el 42 %. El 58.8 % presentó prescripción asociada a úlcera péptica, enfermedad de reflujo gastroesofágico, infecciones por H. pylori, hemorragia gastrointestinal y consumo de AINEs. El 12.8 % consume Clopidogrel de manera concomitante lo que disminuye la absorción de vitamina B12 y hierro. El 45.6 % de pacientes practican polifarmacia. Se identificaron seis errores principales de prescripción y 569 deficiencias. Se diseñó una estrategia de intervención a prescriptores y pacientes para erradicar esos errores y lograr un uso racional de Omeprazol.
Palabras Clave: gastroprotectores, Omeprazol, prescripción
The most widely used gastroprotective drugs are proton pump inhibitors (PPIs) and within these, Omeprazole. Since PPIs were introduced for this purpose, their consumption increased to 450%. Sometimes the prescription of Omeprazole at the community level with gastroprotective use is inadequate, which leads to an irrational use of the drug. The objective of this work was to evaluate the prescription of Omeprazole in the treatment of gastrointestinal diseases in patients of the U-655 Permanent Municipal Main Pharmacy of the Placetas municipality, Villa Clara in the period of January-July 2021. A study was carried out descriptive, retrospective, cross-sectional. The sample was made up of 250 patients. The consumption of Omeprazole in females predominated. The group over 60 years old was higher with 76.4%. 37.2% have Higher Level training. Most of the prescriptions were indicated by Gastroenterologists for no more than 90 days. Mainly the errors in the prescription were observed in Integral General Medicine with 42%. 58.8% presented a prescription associated with peptic ulcer, gastroesophageal reflux disease, H. pylori infections, gastrointestinal bleeding, and use of NSAIDs. 12.8% consume Clopidogrel concomitantly, which decreases the absorption of vitamin B12 and iron. 45.6% of patients practice polypharmacy. Six main prescribing errors and 569 deficiencies were identified. An intervention strategy was designed for prescribers and patients to eradicate these errors and achieve a rational use of Omeprazole. Key Words: gastroprotectors, Omeprazole, prescription
The most widely used gastroprotective drugs are proton pump inhibitors (PPIs) and within these, Omeprazole. Since PPIs were introduced for this purpose, their consumption increased to 450%. Sometimes the prescription of Omeprazole at the community level with gastroprotective use is inadequate, which leads to an irrational use of the drug. The objective of this work was to evaluate the prescription of Omeprazole in the treatment of gastrointestinal diseases in patients of the U-655 Permanent Municipal Main Pharmacy of the Placetas municipality, Villa Clara in the period of January-July 2021. A study was carried out descriptive, retrospective, cross-sectional. The sample was made up of 250 patients. The consumption of Omeprazole in females predominated. The group over 60 years old was higher with 76.4%. 37.2% have Higher Level training. Most of the prescriptions were indicated by Gastroenterologists for no more than 90 days. Mainly the errors in the prescription were observed in Integral General Medicine with 42%. 58.8% presented a prescription associated with peptic ulcer, gastroesophageal reflux disease, H. pylori infections, gastrointestinal bleeding, and use of NSAIDs. 12.8% consume Clopidogrel concomitantly, which decreases the absorption of vitamin B12 and iron. 45.6% of patients practice polypharmacy. Six main prescribing errors and 569 deficiencies were identified. An intervention strategy was designed for prescribers and patients to eradicate these errors and achieve a rational use of Omeprazole. Key Words: gastroprotectors, Omeprazole, prescription
Descripción
Palabras clave
Enfermedades Gastrointestinales, Prescripciones de Medicamentos, Omeprazol